<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD1634932">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <title>Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Lutz E.</namePart>
                        <namePart type="family">Kraushaar</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Alexander</namePart>
                        <namePart type="family">Kr√§mer</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0003-2774-7860</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2009</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Background: Cardiovascular and diabetic disease are the leading and preventable causes of death worldwide. The currently prognosticated dramatic increase in disease burden over the next two decades, however, bespeaks a low confidence in our prevention ability. This conflicts with the almost enthusiastic reporting of study results, which demonstrate substantial risk reductions secondary to simple lifestyle changes. Discussion: There is a case to be made for a disregard of the difference between statistical significance and clinical relevance of the reported data. Nevertheless, lifestyle change remains the main weapon in our battle against the epidemic of cardiometabolic disease. But along the way from risk screening to intervention to maintenance the compound inefficiencies of current primary preventive strategies marginalize their impact. Summary: Unless we dramatically change the ways in which we deploy preventive interventions we will inevitably lose the battle. In this paper we will argue for three provocative strategy changes, namely (a) the disbanding of screening in favor of population-wide enrollment into preventive interventions, (b) the substitution of the current cost utility analysis for a return-on-investment centered appraisal of interventions, and (c) the replacement of standardized programs modeled around acute care by individualized and perpetual interventions.</abstract>
                    <subject>
                    </subject>
                    <classification authority="ddc">610</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>BMC Public Health</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>9</number>
                            </detail>
                            <detail type="issue">
                                <number>1</number>
                            </detail>
                            <extent unit="page">
                                <start>64</start>
                            </extent>
                        </part>
                    </relatedItem>
                    <identifier type="issn">1471-2458</identifier>
                    <identifier type="MEDLINE">19232132</identifier>
                    <identifier type="ISI">000264290500001</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-16349320</identifier>
                    <identifier type="doi">10.1186/1471-2458-9-64</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://rightsstatements.org/vocab/InC/1.0/">Urheberrechtsschutz</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_1634932</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_1634932">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/1634932/2311145/BMC_23.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_1634932" DMDID="DMD1634932">
            <mets:fptr FILEID="FILE0_bielefeld_pub_1634932"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
